|

EIS-12656 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Eisbach Bio GmbH1

Indications

  • HRR Deficiency1
  • Homologous Recombination Deficiency1
  • Advanced Solid Tumor1
  • Cancer1

Houston, Texas1 trial

EIS-12656 as Single Agent and in Combination in Patients With Specified Solid Tumors

MD Anderson Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.